Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03075202 · ClinicalTrials.gov registry record
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1
- Enrollment target
NCT03075202: Completed study, sponsored by Weill Medical College of Cornell University.
NCT03075202 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03075202 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
It is well established in the scientific literature that people with schizophrenia smoke tobacco cigarettes at rates up to three times that of the general population, relapse more frequently, and die an average of 25 years earlier from cigarette smoking and other life-style attributable illnesses. Electronic cigarettes (e-cigarettes) are becoming increasingly popular with smokers worldwide and new research suggests that e-cigarettes are appealing to smokers with schizophrenia. There is a paucity of research focused on the experience of smokers with schizophrenia who decide to try an e-cigarette. A well-designed prospective-observational study is needed to learn more about the influence of e-cigarette use on cigarette smoking behavior and mental and physical health among smokers with schizophrenia. In response, the investigators have designed a study titled, Role of an electronic cigarette on smoking displacement in smokers with schizophrenia: A prospective 3-month pilot study (SchizEcig).
Primary Outcome
The primary endpoint of this study is the proportion of study participants with a self-reported complete displacement from tobacco cigarette smoking - not even a puff in between study visits, along with confirmatory eCO values ≤10 ppm at each study visit. These participants will be referred to as "Displacers". Discrepancies between self-report and eCO measures will be handled on a case-by-case basis. To assure an accurate eCO reading participants will be asked not to smoke cigarettes within one
Interventions
- DEVICE e-cigarette, brand name JUUL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2018-12-24 |
What the finished NCT03075202 record still lists
NCT03075202 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which e-cigarette, brand name JUUL is the first listed.
NCT03075202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03075202 about?
NCT03075202 is a clinical study titled "Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia". It is well established in the scientific literature that people with schizophrenia smoke tobacco cigarettes at rates up to three times that of the general population, relapse more frequently, and die an average of 25 years earlier from cigarette smoking and other life-style attributable illnesses. E...
What is the current status of trial NCT03075202?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2017-03-03. Estimated completion is 2018-12-24.
What interventions are being tested in trial NCT03075202?
The interventions under investigation include: e-cigarette, brand name JUUL (DEVICE).
Who is sponsoring clinical trial NCT03075202?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI